Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2783PDF: 1002HTML: 5513 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1701PDF: 830HTML: 142 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1242PDF: 860HTML: 277 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4704PDF: 1544HTML: 2246Untitled: 204Untitled: 219Untitled: 228Untitled: 210Untitled: 212 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3655PDF: 1426HTML: 180 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2202PDF: 935HTML: 6780Figure 1: 168 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2377PDF: 1579HTML: 614 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3287PDF: 1951HTML: 7471 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1809PDF: 709HTML: 2098Untitled: 208Untitled: 150Untitled: 166Untitled: 151Untitled: 160Untitled: 174Untitled: 181 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3296PDF: 1233HTML: 2193 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4760PDF: 1757HTML: 2701Untitled: 211 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1335PDF: 806HTML: 1022Untitled: 183 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1541PDF: 1192HTML: 185 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3107PDF: 1814HTML: 3564 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2457PDF: 1149HTML: 11791 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1360PDF: 1413PDF: 1003HTML: 202 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2755PDF: 1011HTML: 356Preferred Reviewers: 203 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
715PDF: 463HTML: 6261 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2160PDF: 1190HTML: 3702 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3664PDF: 1231HTML: 3876Untitled: 206Untitled: 256 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1023PDF: 371HTML: 87 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3352PDF: 1276HTML: 2212Fi.1 Gritti.Rambaldi: 203 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4069PDF: 1927HTML: 1760 -
SOLITARY PLASMACYTOMA
3821PDF: 2167HTML: 1215fIGURES 1,2: 209 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3564PDF: 874HTML: 6708 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2429PDF: 780HTML: 1731







